Le Programme 2024
Jeudi - 10 Octobre
Vendredi - 11 Octobre
08:30
WELCOME COFFEE
Jeudi
08:50
INTRODUCTION
Franck BLADOU / Wassim KASSOUF
Jeudi
09:00
JOINT SESSION: Management of histological variants
Chairs: Eva COMPERAT / Laurence ALBIGES
- Prostate cancer – Alexander WYATT
- Bladder cancer – Benjamin PRADERE
- Kidney cancer – Philippe BARTHELEMY
- Discussion
Jeudi
09:50
Role of systemic intensification at the time of diagnosis of prostate cancer - With the support of BAYER
Chair: Damien POUESSEL
- At localized stage – Bertrand TOMBAL
- At metastatic stage – Guillaume PLOUSSARD
- Discussion
10:35 - 11:00
COFFEE BREAK AND EXHIBITION VISIT
Jeudi
11:00
BLADDER CANCER
Chairs: Wassim KASSOUF / Vérane ACHARD / Morgan ROUPRET
- Bladder preservation is a SOC in muscle-invasive disease: Yes – Vedang MURTHY / No – Morgan ROUPRET
- BCG unresponsive NMIBC: Systemic – Benjamin PRADERE / Intravesical – Evanguelos XYLINAS
- Discussion
Jeudi
12:00
Optimizing treatment of genitourinary cancers in 2024 - With the support of ASTELLAS
Chair: Bertrand TOMBAL
- High risk non metastatic BCR or oligometastatic disease? Stephen FREEDLAND
- NHT monotherapy: from localized to M1 disease. Where do we stand? Bertrand TOMBAL
- Metastatic utothelial carcinoma: new treatments and sequences – Thomas POWLES
- Discussion
13:00 - 14:00
LUNCH AND EXHIBITION VISIT
Jeudi
14:00
Artificial intelligence and radiotherapy: Where do we stand?
- Alejandro BERLIN
Jeudi
14:15
How to achieve complete response in mRCC: Who and when? With the support of EISAI / MSD
Chair: Philippe BARTHELEMY
- The choice of systemic treatment – Yann VANO
- Place of stereotactic radiotherapy to achieve a complete response – Mario TERLIZZI
- Favorable IMDC mCCRC: combination for everyone? Philippe BARTHELEMY
- Discussion
Jeudi
15:15
TESTIS AND PENILE CANCERS
Chairs: Xavier DURAND / Ludovic FERRETI
- RPLND in germ cell tumors: state-of-the-art – Nicolas DOUMERC
- Brachytherapy for penile cancer: state-of-the-art – Vedang MURTHY
- Discussion
15:45 - 16:15
COFEE BREAK AND EXHIBITION VISIT
Jeudi
16:15
Urologic cancers: From molecular to clinical application - With the support of JANSSEN
Chairs: Guilhem ROUBAUD
- How is mHSPC landscape evolving? Kim CHI / Alexander WYATT
- mCRPC: how to use PARP inhibitors? Kim CHI / Alexander WYATT
- What’s new in bladder cancer? Yohann LORIOT / Alexander WYATT
- Discussion
Jeudi
17:15
UROTHELIAL CANCER
Chairs: Delphine BORCHIELLINI / Thomas ZILLI
- Should we intensify upfront BCG treatment in high risk NMIBC? – Yohann LORIOT
- Multimodal strategy in locally advanced upper urinary tract carcinoma – Wassim KASSOUF
- Oligometastatic bladder cancer: truth and myths? – Thomas ZILLI
- Discussion
Jeudi
18:00
SPECIAL GUEST
- Ugo MOLA
18:30
END OF THE DAY ONE
09:00
START
Vendredi
09:00
Supportive care in urologic cancers - With the support of IPSEN
Chairs: Karim BENSALAH / Carole HELISSEY
- Role of the Adapted Physical Activity (APA) in the support of urologic cancers – Karim BENSALAH
- mRCC: Optimization of therapeutic care and management of tolerance: what has changed and how this impacts our practices? Delphine BORCHIELLINI
- How Quality-of-life should guide our treatment decision-making? – Carole HELISSEY
Vendredi
10:00
Association Française d'Urologie Lecture
Chairs: Karim BENSALAH / Alexandre de la TAILLE /Andrew LOBLAW
- SBRT for localized renal cancer – Shankar SIVA
- Renaming ISUP1: Yes – Gaëlle FIARD
- Renaming ISUP1: No – Michael BABOUDJIAN
10:30 - 11:00
COFFEE BREAK AND EXHIBITION VISIT
Vendredi
11:00
Adjuvant treatment in GU cancers: Where do we stand in 2024? With the support of BMS
Chairs: Paul SARGOS / Laurence ALBIGES / Wassim KASSOUF
- Prostate cancer – Jonathan KHALIFA
- Urothelial cancer – Wassim KASSOUF
- Kidney cancer – Laurence ALBIGES
- Discussion
Vendredi
12:00
PROSTATE CANCER: Loco-regional treatment of very high risk PCa (STAMPEDE M0)
Chairs : Franck BLADOU / Ronan FLIPPOT / Thomas ZILLI
- Clinical case – Ronan FLIPPOT
- Surgery – Jochen WALTZ
- Radiotherapy – Andrew LOBLAW
- Discussion
13:00 - 14:00
LUNCH AND EXHIBITION VISIT
Vendredi
14:00
LOCAL TREATMENT OPTIMIZATION
Chairs: Jochen WALZ / Vedang MURTHY / Shankar SIVA
- Early detection of prostate cancer
- Why we have to do it? Michael BABOUDJIAN
- Why we should better delay the diagnosis? Gaëlle FIARD
- Discussion
- Organ-sparing RC in female patients – Gregory VERHOEST
- How to optimize SBRT in localized PCa? Andrew LOBLAW
- Discussion
Vendredi
15:00
Nuclear Medicine in G-U cancer: What's new in 2024? With the support of ADACAP
Chair: Stéphan SUPIOT
- New radiotracers in G-U cancer – Stefan PROBST
- Internal vectorized radiotherapy: earlier is better? M1 – Denis MAILLET
- Internal vectorized radiotherapy: earlier is better? M0 – Thomas SEISEN
- Discussion
Vendredi
16:00
MUST READ ARTICLE
Chairs: Wassim KASSOUF / Franck BLADOU
- Diego TEYSSONNEAU
Vendredi
16:15
CONCLUSION
Wassim KASSOUF / Franck BLADOU
